공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 의료 진단용 AI 시장 예측(-2025년) : 컴포넌트(소프트웨어, 서비스), 용도(체내 진단, 방사선, OBGY, MRI, CT, 초음파, IVD), 최종사용자(병원, 진단 랩, 영상 진단 센터), 지역별

Artificial Intelligence (Ai) in Medical Diagnostics Market by Component (Software, Service), Application (In Vivo, Radiology, OBGY,MRI, CT, Ultrasound, IVD), End User (Hospital, Diagnostic Laboratory, Diagnostic Imaging Center)- Global Forecast to 2025

리서치사 MarketsandMarkets
발행일 2021년 04월 상품 코드 1001808
페이지 정보 영문 167 Pages
가격
US $ 4,950 ₩ 5,599,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,650 ₩ 7,522,000 PDF (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,150 ₩ 9,219,000 PDF (Corporate License) help
기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없지만, 동일 국가의 동일 사업장에 한정되며 해외지점 등은 포함되지 않습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 10,000 ₩ 11,312,000 PDF (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 의료 진단용 AI 시장 예측(-2025년) : 컴포넌트(소프트웨어, 서비스), 용도(체내 진단, 방사선, OBGY, MRI, CT, 초음파, IVD), 최종사용자(병원, 진단 랩, 영상 진단 센터), 지역별 Artificial Intelligence (Ai) in Medical Diagnostics Market by Component (Software, Service), Application (In Vivo, Radiology, OBGY,MRI, CT, Ultrasound, IVD), End User (Hospital, Diagnostic Laboratory, Diagnostic Imaging Center)- Global Forecast to 2025
발행일 : 2021년 04월 페이지 정보 : 영문 167 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

의료 진단용 AI 시장 규모는 예측 기간 중 50.2%의 CAGR로 추이하며, 2020년 5억 500만 달러에서 2025년에는 38억 6800만 달러 규모로 성장할 것으로 예측됩니다.

AI 기반 기술의 도입을 촉진하는 정부 구상, 의료 분야에서 AI툴의 수요 증가, 방사선과의 작업 부하 경감에 대한 관심의 증가, 대규모 복잡한 데이터세트의 유입, AI 기반 스타트업 기업에 대한 자금 제공의 증가, 업계를 초월한 파트너십 및 협력 관계의 증가 등의 요인이 이 시장의 성장을 촉진하고 있습니다.

컴포넌트별로는 소프트웨어 부문이 최대의 CAGR로 성장할 것으로 예측되고 있습니다. 또한 최종사용자별로는 병원 부문이 2019년에 64.1%의 점유율을 보이고 있습니다. 병원에서 시행되는 영상 진단 수의 증가, 병원에서 자동화·디지털화에 대한 경향의 확대, 저침습수술의 채택 증가, 워크플로우의 효율 향상을 위한 첨단 영상 진단법의 채택 증가 등의 요인이 이 부문의 성장을 촉진하고 있습니다.

세계의 의료 진단용 AI 시장을 조사했으며, 시장의 정의와 개요, 밸류체인, 신종 코로나바이러스 감염증(COVID-19) 및 기타 시장 영향요인 분석, 법규제 환경, 기술 동향, 사례 연구, 시장 규모의 추이·예측, 컴포넌트·용도·최종사용자·지역/주요 국가별 내역, 경쟁 환경, 주요 기업의 개요 등을 정리하여 전해드립니다.

제1장 서론

제2장 조사 방법

제3장 개요

제4장 중요 인사이트

제5장 시장 개요

    • 촉진요인
    • 억제요인
    • 시장 기회
    • 과제
  • 밸류체인 분석
  • 사례 연구
  • COVID-19의 영향
  • 에코시스템
  • 기술 분석
  • 규칙
  • 가격 분석

제6장 시장 분석·예측 : 컴포넌트별

  • 소프트웨어
  • 서비스

제7장 시장 분석·예측 : 용도별

  • 체내 진단
    • 전문 분야별
    • 모달리티별
  • 체외진단

제8장 시장 분석·예측 : 최종사용자별

  • 병원
  • 진단 영상 센터
  • 진단 랩
  • 기타

제9장 시장 분석·예측 : 지역·주요 국가별

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 영국
    • 프랑스
    • 기타
  • 아시아태평양
    • 중국
    • 일본
    • 인도
    • 기타
  • 기타 지역

제10장 경쟁 구도

  • 개요
  • 주요 기업의 전략
  • 기업 순위
  • 경쟁 리더십 지도제작
  • 기업의 제품 발자국
  • 경쟁 시나리오

제11장 기업 개요

  • 주요 기업
    • MICROSOFT CORPORATION
    • NVIDIA
    • IBM
    • INTEL
    • GOOGLE
    • SIEMENS HEALTHINEERS
    • GE HEALTHCARE
  • 기타 기업
    • DIGITAL DIAGNOSTICS
    • XILINX
    • INFORMAI
    • HEARTFLOW
    • ENLITIC
    • DAY ZERO DIAGNOSTICS
    • AIDENCE
    • BUTTERFLY NETWORK, INC.
    • PROGNOS
    • ZEBRA MEDICAL VISION
    • VIZ.AI
    • QUIBIM
    • QURE.AI
    • THERAPIXEL

제12장 부록

KSA 21.05.03

The global AI in medical diagnostics market is projected to reach USD 3,868 million by 2025 from USD 505 million in 2020, at a CAGR of 50.2% during the forecast period. Growth in this market is primarily driven by government initiatives to increase the adoption of AI-based technologies, increasing demand for AI tools in the medical field, growing focus on reducing the workload of radiologists, influx of large and complex datasets, growth in funding for AI-based start-ups, and the growing number of cross-industry partnerships and collaborations.

Software segment is expected to grow at the highest CAGR

On the basis of component, the AI in medical diagnostics market is segmented into software and services. The services segment dominated this market in 2020, while the software segment is estimated to grow at a higher CAGR during the forecast period. Software solutions help healthcare providers gain a competitive edge despite the challenges of being short-staffed and facing increasing imaging scan volumes. This is a key factor driving the growth of the software segment.

Hospitals to establish the largest market size of AI in medical diagnostics market

Based on end user, the AI in medical diagnostics market is segmented into hospitals, diagnostic imaging centers, diagnostic laboratories, and other end users. The hospitals segment commanded the largest share of 64.1% of this market in 2019. The large share of this segment can be attributed to the rising number of diagnostic imaging procedures performed in hospitals, the growing inclination of hospitals toward the automation and digitization of radiology patient workflow, increasing adoption of minimally invasive procedures in hospitals to improve the quality of patient care, and the rising adoption of advanced imaging modalities to improve workflow efficiency.

North America To Witness Significant Growth From 2020 To 2025

The AI in medical diagnostics market has been segmented into four main regional segments, namely, North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America accounted for the largest market share of 37.6%. However, the APAC market is projected to register the highest CAGR of 53.2% during the forecast period, primarily due to the growth strategies adopted by companies in emerging markets, improved medical diagnostic infrastructure, increasing geriatric population, rising prevalence of cancer, and the implementation of favorable government initiatives.

Breakdown of supply-side primary interviews: * By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30% * By Designation: C-level - 27%, Director-level - 18%, and Others - 55% * By Region: North America - 40%, Europe - 20%, APAC - 30%, Rest of the World - 10%

Some of the prominent players operating in the AI in medical diagnostics market are Microsoft Corporation (US), NVIDIA (US), IBM (US), Intel (US), Siemens Healthineers (Germany), GE Healthcare (US), Digital Diagnostics (US), Xilinx (US), InformAI (US), Enlitic (US), Day Zero Diagnostics (US), Aidence (Netherlands), Butterfly Network, Inc. (US), Prognos (US), Zebra Medical Vision (Israel), Viz.ai (US), Quibin (Spain), Qure.ai (India), Therapixel (France), and HeartFlow (US).

Research Coverage

This report studies the AI in medical diagnosticsmarket based on component, end user, application, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.

Key Benefits of Buying the Report

This report focuses on various levels of analysis-industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 INCLUSIONS & EXCLUSIONS
    • 1.3.1 MARKETS COVERED
    • FIGURE 1 AI IN MEDICAL DIAGNOSTICS MARKET SEGMENTATION
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH METHODOLOGY STEPS
    • FIGURE 2 RESEARCH METHODOLOGY: AI IN MEDICAL DIAGNOSTICS MARKET
    • FIGURE 3 RESEARCH DESIGN
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    • FIGURE 5 PRIMARY SOURCES
      • 2.2.2.1 Key data from primary sources
  • 2.3 MARKET SIZE ESTIMATION METHODOLOGY
    • FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • FIGURE 7 MARKET SIZE ESTIMATION
  • 2.4 MARKET DATA ESTIMATION AND TRIANGULATION
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.5 ASSUMPTIONS FOR THE STUDY
  • 2.6 COVID-19-SPECIFIC ASSUMPTIONS

3 EXECUTIVE SUMMARY

    • FIGURE 9 AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2020 VS. 2025 (USD MILLION)
    • FIGURE 10 AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
    • FIGURE 11 AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
    • FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE AI IN MEDICAL DIAGNOSTICS MARKET

4 PREMIUM INSIGHTS

  • 4.1 AI IN MEDICAL DIAGNOSTICS MARKET OVERVIEW
    • FIGURE 13 INFLUX OF LARGE AND COMPLEX DATASETS IN HEALTHCARE TO DRIVE MARKET GROWTH
  • 4.2 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION AND COUNTRY (2019)
    • FIGURE 14 IN VIVO DIAGNOSTIC APPLICATIONS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2019
  • 4.3 AI IN MEDICAL DIAGNOSTICS MARKET SHARE, BY APPLICATION, 2020 VS. 2025
    • FIGURE 15 IN VIVO DIAGNOSTIC APPLICATIONS SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2025
  • 4.4 AI IN MEDICAL DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 16 APAC MARKET TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
    • FIGURE 17 AI IN MEDICAL DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.1.1 DRIVERS
      • 5.1.1.1 Influx of large and complex datasets
      • 5.1.1.2 Growing number of cross-industry partnerships and collaborations
      • 5.1.1.3 Increasing demand for AI tools in the medical imaging field and rising focus on reducing the workload of radiologists
      • 5.1.1.4 Government initiative to increase the adoption of AI-based technologies
      • 5.1.1.5 Growth in funding for AI-based start-ups
    • 5.1.2 RESTRAINTS
      • 5.1.2.1 Reluctance among medical practitioners to adopt AI-based technologies
      • 5.1.2.2 Lack of skilled AI workforce and ambiguous regulatory guidelines for medical software
    • 5.1.3 OPPORTUNITIES
      • 5.1.3.1 Untapped emerging markets
      • 5.1.3.2 Growing potential of AI-technology in imaging & diagnostics to fight COVID-19
      • 5.1.3.3 Increasing focus on developing human-aware AI systems
    • 5.1.4 CHALLENGES
      • 5.1.4.1 Budgetary constraints
      • 5.1.4.2 Lack of curated healthcare data
      • 5.1.4.3 Concerns regarding data privacy
    • FIGURE 18 TYPES OF HEALTHCARE BREACHES REPORTED TO THE US DEPARTMENT OF HEALTH AND HUMAN SERVICES (2018 TO 2020)
      • 5.1.4.4 Lack of interoperability between AI solutions offered by different vendors
  • 5.2 VALUE CHAIN ANALYSIS
    • FIGURE 19 AI IN MEDICAL DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS
  • 5.3 CASE STUDIES
    • 5.3.1 FOCUS ON IMPROVING WORKFLOW EFFICACY AND REDUCING THE BURDEN ON RADIOLOGISTS
      • 5.3.1.1 Use case 1: Reducing the burden on radiologists by developing and testing an AI model to read large ultrasound data
    • 5.3.2 IMPROVED TRIAGE
      • 5.3.2.1 Use case 2: Precision Driven Health developed ML model to help improve work triage of cardiologists (2019)
  • 5.4 IMPACT OF COVID-19 ON THE AI IN MEDICAL DIAGNOSTICS MARKET
    • FIGURE 20 PRE- AND POST-COVID-19 IMPACT ANALYSIS
  • 5.5 ECOSYSTEM COVERAGE
    • FIGURE 21 AI IN MEDICAL DIAGNOSTICS ECOSYSTEM
  • 5.6 TECHNOLOGY ANALYSIS
    • TABLE 1 TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS
  • 5.7 REGULATIONS
    • 5.7.1 HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT OF 1996 (HIPAA)
    • 5.7.2 HEALTH INFORMATION TECHNOLOGY FOR ECONOMIC AND CLINICAL HEALTH ACT OF 2009 (HITECH)
    • 5.7.3 CONSUMER PRIVACY PROTECTION ACT OF 2017
    • 5.7.4 NATIONAL CYBERSECURITY PROTECTION ADVANCEMENT ACT OF 2015
    • 5.7.5 FUTURE OF LIFE INSTITUTE'S ASILOMAR AI PRINCIPLES
    • 5.7.6 THE EUROPEAN MEDICAL DEVICES REGULATION (EU) 2017/745 AND IN-VITRO DIAGNOSTIC MEDICAL DEVICES REGULATION (EU) 2017/746 IN COMBINATION WITH THE GENERAL DATA PROTECTION REGULATION 2016/679
    • 5.7.7 THE CYBERSECURITY LAW OF THE PEOPLE'S REPUBLIC OF CHINA
  • 5.8 PRICING ANALYSIS

6 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT

  • 6.1 INTRODUCTION
    • TABLE 2 AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • 6.1.1 SOFTWARE
      • 6.1.1.1 Software segment to witness higher growth during the forecast period
    • TABLE 3 AI IN MEDICAL DIAGNOSTICS SOFTWARE MARKET, BY REGION, 2018-2025 (USD MILLION)
    • 6.1.2 SERVICES
      • 6.1.2.1 Services segment to account for a larger share of the market during the forecast period
    • TABLE 4 AI IN MEDICAL DIAGNOSTICS SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION)

7 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
    • TABLE 5 AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • 7.2 IN VIVO DIAGNOSTICS
    • TABLE 6 AI IN IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • 7.2.1 IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY
    • TABLE 7 AI IN IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY, 2018-2025 (USD MILLION)
      • 7.2.1.1 Radiology
        • 7.2.1.1.1 AI-based diagnostic tools help ease the workflow of radiologists
    • TABLE 8 AI IN RADIOLOGY MARKET, BY REGION, 2018-2025 (USD MILLION)
      • 7.2.1.2 Cardiology
        • 7.2.1.2.1 Increased complexity of sudden cardiac diseases to drive market growth
    • TABLE 9 AI IN CARDIOLOGY MARKET, BY REGION, 2018-2025 (USD MILLION)
      • 7.2.1.3 Neurology
        • 7.2.1.3.1 Increased start-up funding to drive market growth
    • TABLE 10 AI IN NEUROLOGY MARKET, BY REGION, 2018-2025 (USD MILLION)
      • 7.2.1.4 Obstetrics/gynecology
        • 7.2.1.4.1 Rising use of minimally invasive techniques in gynecology procedures to drive market growth
    • TABLE 11 AI IN OBSTETRICS/GYNECOLOGY MARKET, BY REGION, 2018-2025 (USD MILLION)
      • 7.2.1.5 Ophthalmology
        • 7.2.1.5.1 Need for early detection and prevention of eye diseases driving the adoption of AI-based diagnostic tools
    • TABLE 12 AI IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2025 (USD MILLION)
      • 7.2.1.6 Other specialties
    • TABLE 13 AI IN OTHER SPECIALTIES MARKET, BY REGION, 2018-2025 (USD MILLION)
    • 7.2.2 IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY
    • TABLE 14 AI IN IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY, 2018-2025 (USD MILLION)
      • 7.2.2.1 Computed tomography
        • 7.2.2.1.1 Need for efficient diagnosis will drive the adoption of AI in computed tomography
    • TABLE 15 AI IN COMPUTED TOMOGRAPHY MARKET, BY REGION, 2018-2025 (USD MILLION)
      • 7.2.2.2 X-ray
        • 7.2.2.2.1 Companies such as NVIDIA, Intel, and Xilinx are developing AI-based tools exclusively in this space
    • TABLE 16 AI IN X-RAY MARKET, BY REGION, 2018-2025 (USD MILLION)
      • 7.2.2.3 Magnetic resonance imaging
        • 7.2.2.3.1 Increasing burden of brain-related disorders to drive the adoption of AI in magnetic resonance imaging
    • TABLE 17 AI IN MAGNETIC RESONANCE IMAGING MARKET, BY REGION, 2018-2025 (USD MILLION)
      • 7.2.2.4 Ultrasound
        • 7.2.2.4.1 Increasing prevalence of ovarian cancer and the need for its early diagnosis will drive market growth
    • TABLE 18 AI IN ULTRASOUND MARKET, BY REGION, 2018-2025 (USD MILLION)
      • 7.2.2.5 Other modalities
    • TABLE 19 AI IN OTHER MODALITIES MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 7.3 IN VITRO DIAGNOSTICS
    • TABLE 20 AI IN IN VITRO DIAGNOSTIC APPLICATIONS MARKET, BY REGION, 2018-2025 (USD MILLION)

8 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 21 AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 8.2 HOSPITALS
    • 8.2.1 LARGE HOSPITALS HAVE BEEN THE EARLY ADOPTERS OF AI SOLUTIONS FOR DIAGNOSTIC IMAGING
    • TABLE 22 AI IN MEDICAL DIAGNOSTICS MARKET FOR HOSPITALS, BY REGION, 2018-2025 (USD MILLION)
  • 8.3 DIAGNOSTIC IMAGING CENTERS
    • 8.3.1 INCREASING NUMBER OF PRIVATE IMAGING CENTERS IS CONTRIBUTING TO MARKET GROWTH
    • TABLE 23 AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2025 (USD MILLION)
  • 8.4 DIAGNOSTIC LABORATORIES
    • 8.4.1 INCREASING SPECIMEN TEST VOLUMES AND WORKLOAD OF PATHOLOGISTS HAS BOOSTED THE MARKET GROWTH
    • TABLE 24 AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2018-2025 (USD MILLION)
  • 8.5 OTHER END USERS
    • TABLE 25 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION, 2018-2025 (USD MILLION)

9 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 26 AI IN MEDICAL DIAGNOSTICS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 22 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET SNAPSHOT
    • TABLE 27 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 28 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 29 NORTH AMERICA: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY, 2018-2025 (USD MILLION)
    • TABLE 30 NORTH AMERICA: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY, 2018-2025 (USD MILLION)
    • TABLE 31 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 32 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 Increasing volume of imaging procedures to drive market growth in the US
    • TABLE 33 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 34 US: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY, 2018-2025 (USD MILLION)
    • TABLE 35 US: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY, 2018-2025 (USD MILLION)
    • TABLE 36 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 37 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 Research grants and improved academics in the field of radiology to boost market growth in Canada
    • TABLE 38 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 39 CANADA: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY, 2018-2025 (USD MILLION)
    • TABLE 40 CANADA: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY, 2018-2025 (USD MILLION)
    • TABLE 41 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 42 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 43 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 44 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 45 EUROPE: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY, 2018-2025 (USD MILLION)
    • TABLE 46 EUROPE: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY, 2018-2025 (USD MILLION)
    • TABLE 47 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 48 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 Government initiatives to expedite AI development in Germany
    • TABLE 49 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 50 GERMANY: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY, 2018-2025 (USD MILLION)
    • TABLE 51 GERMANY: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY, 2018-2025 (USD MILLION)
    • TABLE 52 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 53 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.2 UK
      • 9.3.2.1 Increasing number of radiography procedures to drive market growth in the UK
    • TABLE 54 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 55 UK: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY, 2018-2025 (USD MILLION)
    • TABLE 56 UK: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY, 2018-2025 (USD MILLION)
    • TABLE 57 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 58 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.3 FRANCE
      • 9.3.3.1 Availability of funding for companies to enhance AI research in medical imaging
    • TABLE 59 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 60 FRANCE: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY, 2018-2025 (USD MILLION)
    • TABLE 61 FRANCE: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY, 2018-2025 (USD MILLION)
    • TABLE 62 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 63 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.4 REST OF EUROPE
    • TABLE 64 ROE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 65 ROE: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY, 2018-2025 (USD MILLION)
    • TABLE 66 ROE: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY, 2018-2025 (USD MILLION)
    • TABLE 67 ROE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 68 ROE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 23 APAC: AI IN MEDICAL DIAGNOSTICS MARKET SNAPSHOT
    • TABLE 69 APAC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 70 APAC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 71 APAC: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY, 2018-2025 (USD MILLION)
    • TABLE 72 APAC: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY, 2018-2025 (USD MILLION)
    • TABLE 73 APAC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 74 APAC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.4.1 CHINA
      • 9.4.1.1 China dominated the APAC market in 2019
    • TABLE 75 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 76 CHINA: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY, 2018-2025 (USD MILLION)
    • TABLE 77 CHINA: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY, 2018-2025 (USD MILLION)
    • TABLE 78 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 79 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.4.2 JAPAN
      • 9.4.2.1 Presence of a strong infrastructure to drive the adoption of AI in Japan
    • TABLE 80 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 81 JAPAN: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY, 2018-2025 (USD MILLION)
    • TABLE 82 JAPAN: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY, 2018-2025 (USD MILLION)
    • TABLE 83 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 84 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.4.3 INDIA
      • 9.4.3.1 Favorable government initiatives to boost market growth in India
    • TABLE 85 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 86 INDIA: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY, 2018-2025 (USD MILLION)
    • TABLE 87 INDIA: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY, 2018-2025 (USD MILLION)
    • TABLE 88 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 89 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.4.4 REST OF ASIA PACIFIC
    • TABLE 90 ROAPAC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 91 ROAPAC: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY, 2018-2025 (USD MILLION)
    • TABLE 92 ROAPAC: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY, 2018-2025 (USD MILLION)
    • TABLE 93 ROAPAC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 94 ROAPAC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 9.5 REST OF THE WORLD
    • TABLE 95 ROW: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 96 ROW: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY, 2018-2025 (USD MILLION)
    • TABLE 97 ROW: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY, 2018-2025 (USD MILLION)
    • TABLE 98 ROW: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 99 ROW: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2018-2025 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
    • FIGURE 24 MARKET EVALUATION FRAMEWORK, 2018-2021
  • 10.2 KEY PLAYER STRATEGIES
  • 10.3 RANKING OF PLAYERS, 2019
    • FIGURE 25 RANKING OF KEY COMPANIES IN THE AI IN MEDICAL DIAGNOSTICS MARKET (2019)
  • 10.4 COMPETITIVE LEADERSHIP MAPPING
    • 10.4.1 STARS
    • 10.4.2 EMERGING LEADERS
    • 10.4.3 PERVASIVE PLAYERS
    • 10.4.4 PARTICIPANTS
    • FIGURE 26 AI IN MEDICAL DIAGNOSTICS MARKET: COMPETITIVE LEADERSHIP MAPPING (2019)
  • 10.5 COMPETITIVE LEADERSHIP MAPPING (START-UPS)
    • 10.5.1 PROGRESSIVE COMPANIES
    • 10.5.2 DYNAMIC COMPANIES
    • 10.5.3 RESPONSIVE COMPANIES
    • 10.5.4 STARTING BLOCKS
    • FIGURE 27 AI IN MEDICAL DIAGNOSTICS MARKET (START-UPS): COMPETITIVE LEADERSHIP MAPPING (2019)
  • 10.6 COMPANY PRODUCT FOOTPRINT
    • TABLE 100 FOOTPRINT OF COMPANIES
    • TABLE 101 APPLICATION FOOTPRINT OF COMPANIES
    • TABLE 102 REGIONAL FOOTPRINT OF COMPANIES
  • 10.7 COMPETITIVE SCENARIO
    • TABLE 103 AI IN MEDICAL DIAGNOSTICS MARKET: PRODUCT LAUNCHES, 2018-2021
    • TABLE 104 AI IN MEDICAL DIAGNOSTICS MARKET: DEALS, 2018-2021
    • TABLE 105 AI IN MEDICAL DIAGNOSTICS MARKET: OTHER DEVELOPMENTS, 2018-2021

11 COMPANY PROFILES

  • 11.1 MAJOR PLAYERS
  • (Business Overview, Products Offered, Recent Developments, MnM View)**
    • 11.1.1 MICROSOFT CORPORATION
    • TABLE 106 MICROSOFT CORPORATION: BUSINESS OVERVIEW
    • FIGURE 28 MICROSOFT CORPORATION: COMPANY SNAPSHOT
    • TABLE 107 MICROSOFT CORPORATION: PRODUCTS OFFERED
    • 11.1.2 NVIDIA
    • TABLE 108 NVIDIA: BUSINESS OVERVIEW
    • FIGURE 29 NVIDIA: COMPANY SNAPSHOT
    • TABLE 109 NVIDIA: PRODUCTS OFFERED
    • 11.1.3 IBM
    • TABLE 110 IBM: BUSINESS OVERVIEW
    • FIGURE 30 IBM: COMPANY SNAPSHOT
    • TABLE 111 IBM: PRODUCTS OFFERED
    • 11.1.4 INTEL
    • TABLE 112 INTEL: BUSINESS OVERVIEW
    • FIGURE 31 INTEL: COMPANY SNAPSHOT
    • TABLE 113 INTEL: PRODUCTS OFFERED
    • 11.1.5 GOOGLE (SUBSIDIARY OF ALPHABET, INC.)
    • TABLE 114 GOOGLE: BUSINESS OVERVIEW
    • FIGURE 32 GOOGLE: COMPANY SNAPSHOT
    • TABLE 115 GOOGLE: PRODUCTS OFFERED
    • 11.1.6 SIEMENS HEALTHINEERS
    • TABLE 116 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW
    • FIGURE 33 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
    • TABLE 117 SIEMENS HEALTHINEERS: PRODUCTS OFFERED
    • 11.1.7 GE HEALTHCARE
    • TABLE 118 GE HEALTHCARE: BUSINESS OVERVIEW
    • FIGURE 34 GE HEALTHCARE: COMPANY SNAPSHOT
    • TABLE 119 GE HEALTHCARE: PRODUCTS OFFERED
  • 11.2 OTHER PLAYERS
    • 11.2.1 DIGITAL DIAGNOSTICS (FORMERLY KNOWN AS IDX)
    • TABLE 120 DIGITAL DIAGNOSTICS: BUSINESS OVERVIEW
    • TABLE 121 DIGITAL DIAGNOSTICS: PRODUCTS OFFERED
    • 11.2.2 XILINX
    • TABLE 122 XILINX: BUSINESS OVERVIEW
    • FIGURE 35 XILINX: COMPANY SNAPSHOT
    • TABLE 123 XILINX: PRODUCTS OFFERED
    • 11.2.3 INFORMAI
    • TABLE 124 INFORMAI: BUSINESS OVERVIEW
    • TABLE 125 INFROMAI: PRODUCTS OFFERED
    • 11.2.4 HEARTFLOW
    • TABLE 126 HEARTFLOW: BUSINESS OVERVIEW
    • TABLE 127 HEARTFLOW: PRODUCTS OFFERED
    • 11.2.5 ENLITIC
    • TABLE 128 ENLITIC: BUSINESS OVERVIEW
    • TABLE 129 ENLITIC: PRODUCTS OFFERED
    • 11.2.6 DAY ZERO DIAGNOSTICS
    • TABLE 130 DAY ZERO DIAGNOSTICS: BUSINESS OVERVIEW
      • 11.2.6.2 Products offered
    • TABLE 131 DAY ZERO DIAGNOSTICS: PRODUCTS OFFERED
    • 11.2.7 AIDENCE
    • TABLE 132 AIDENCE: BUSINESS OVERVIEW
    • TABLE 133 AIDENCE: PRODUCTS OFFERED
    • 11.2.8 BUTTERFLY NETWORK, INC.
    • TABLE 134 BUTTERFLY NETWORK: BUSINESS OVERVIEW
    • TABLE 135 BUTTERFLY NETWORK: PRODUCTS OFFERED
    • 11.2.9 PROGNOS
    • TABLE 136 PROGNOS: BUSINESS OVERVIEW
    • TABLE 137 PROGNOS: PRODUCTS OFFERED
    • 11.2.10 ZEBRA MEDICAL VISION
    • TABLE 138 ZEBRA MEDICAL VISION: BUSINESS OVERVIEW
    • TABLE 139 ZEBRA MEDICAL VISION: PRODUCTS OFFERED
    • 11.2.11 VIZ.AI
    • TABLE 140 VIZ.AI: BUSINESS OVERVIEW
    • TABLE 141 VIZ.AI: PRODUCTS OFFERED
    • 11.2.12 QUIBIM
    • TABLE 142 QUIBIM: BUSINESS OVERVIEW
    • TABLE 143 QUIBIM: PRODUCTS OFFERED
    • 11.2.13 QURE.AI
    • TABLE 144 QURE.AI: BUSINESS OVERVIEW
    • TABLE 145 QURE.AI: PRODUCTS OFFERED
    • 11.2.14 THERAPIXEL
    • TABLE 146 THERAPIXEL: BUSINESS OVERVIEW
    • TABLE 147 THERAPIXEL: PRODUCTS OFFERED
  • *Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
Back to Top
전화 문의
F A Q